Not content to just put out one twisty movie at the holiday season with Wake Up Dead Man, Netflix decided to open the floodgates – pun fully intended – with South Korean disaster movie The Great Flood ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

The afterlife rom-com/fantasy movie Eternity asks a fairly simple question: Which of the two husbands a 90-something woman married during her lifetime is more important to her, the man she lived with ...

Volume 1 of the final season of "Stranger Things" is now out, and it's left viewers with a bunch of burning questions. In this article explaining the ending of Stranger Things Season 5, you’ll find ...

Netflix's latest “Frankenstein” adaptation is one of the most celebrated yet. In this article, we're recapping everything that occurred and answering the question, ‘What happened at the end of ...

Guillermo Del Toro’s Frankenstein is now out on Netflix, with the monster (played by Jacob Elordi) shown to be far more human than his titular creator. The ending of the Netflix film differs from both ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...